Jane Henney - Alphabet Lead Independent Director
| ABEC Stock | EUR 184.48 5.52 2.91% |
Director
Dr. Jane E. Henney M.D., is the Lead Independent Director of the Company. Dr. Henney has served as our Board Lead Independent Director since March 2016 and as a Director since January 2002. She has served as Home Secretary for the National Academy of Medicine since April 1, 2014. Dr. Henney was a Professor of Medicine at the College of Medicine at the University of Cincinnati from January 2008 until December 2012. She served as Senior Vice President and Provost for Health Affairs at the University of Cincinnati from July 2003 to January 2008 and was the Commissioner of Food and Drugs at the United States Food and Drug Administration from 1998 to 2001. Dr. Henney served as Vice President for Health Sciences at the University of New Mexico from 1994 to 1998. She currently serves as a director for CIGNA Corporation and The China Medical Board. Dr. Henney previously served as a director of AstraZeneca PLC from September 2001 to April 2011 and Cubist Pharmaceuticals, Inc. from March 2012 to January 2014. Dr. Henney is a National Association of Corporationrationrate Directors Board Leadership Fellow. Dr. Henney is a former member of the Board of The Commonwealth Fund and The Monnell Center for the Chemical Senses. since 2016.
| Age | 72 |
| Tenure | 8 years |
| Phone | 650 253 0000 |
| Web | https://www.abc.xyz |
Alphabet Management Efficiency
The company has return on total asset (ROA) of 0.1291 % which means that it generated a profit of $0.1291 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2362 %, meaning that it generated $0.2362 on every $100 dollars invested by stockholders. Alphabet's management efficiency ratios could be used to measure how well Alphabet manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | DIRECTOR Age | ||
| Sheryl Sandberg | Meta Platforms | 49 | |
| Marc Andreessen | Meta Platforms | 46 | |
| Peter Thiel | Meta Platforms | 51 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 |
Alphabet Leadership Team
Elected by the shareholders, the Alphabet's board of directors comprises two types of representatives: Alphabet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alphabet. The board's role is to monitor Alphabet's management team and ensure that shareholders' interests are well served. Alphabet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alphabet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Cleary, Executive Vice President Group President - Global Commercialization Services & Animal Health | ||
| Kathleen hyle, Independent Director | ||
| Lonie Haynes, Senior Vice President Chief Diversity and Inclusion Officer | ||
| Kent Walker, Chief Affairs | ||
| John Chou, Executive Vice President, Chief Legal Officer and Secretary | ||
| Dennis Nally, Independent Director | ||
| Ruth Porat, VP CFO | ||
| Philipp Schindler, Sr Google | ||
| Fiona Cicconi, Chief Officer | ||
| Silvana Battaglia, Chief Human Resource Officer, Executive Vice President | ||
| Leslie Donato, Executive Vice President and Chief Strategy Officer | ||
| Henry McGee, Independent Director | ||
| Michael Long, Independent Director | ||
| Sergey Brin, CoFounder Director | ||
| Amie OToole, Chief VP | ||
| Ellen West, VP Relations | ||
| Larry Page, CoFounder Director | ||
| Steven Collis, Chairman of the Board, President, Chief Executive Officer | ||
| Prabhakar Raghavan, VP Google | ||
| Robert Mauch, Executive Vice President Group President - Pharmaceutical Distribution & Strategic Global Sourcing | ||
| Ornella Barra, Director | ||
| Richard Gochnauer, Independent Director | ||
| Sundar Pichai, CEO Director | ||
| Gina Clark, Executive Vice President Chief Communications & Administration Officer | ||
| Lon Greenberg, Independent Director | ||
| D Durcan, Independent Director | ||
| Jane Henney, Lead Independent Director |
Alphabet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alphabet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 1.09 T | |||
| Shares Outstanding | 5.97 B | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 63.47 % | |||
| Price To Earning | 39.77 X | |||
| Price To Book | 4.81 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Alphabet Stock
Alphabet financial ratios help investors to determine whether Alphabet Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphabet with respect to the benefits of owning Alphabet security.